D-1044-2014 Class III Terminated

Recalled by Fougera Pharmaceuticals Inc. — Melville, NY

FDA drug recall D-1044-2014 was initiated by Fougera Pharmaceuticals Inc. on Nov 18, 2013 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out-of-Specification degradant results. The recall status is terminated (terminated May 9, 2016). Affected quantity: 31,122 tubes.

Recall details

Product Type
Drugs
Report Date
Feb 5, 2014
Initiation Date
Nov 18, 2013
Termination Date
May 9, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31,122 tubes

Product description

KETOCONAZOLE CREAM, 2%, 30 gram tube, Rx only, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0099-30, UPC 3 0168-0099-30 9.

Reason for recall

Failed Impurities/Degradation Specifications: Out-of-Specification degradant results.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: 495P, Exp 07/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1044-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1044-2014. Report a data issue: hello@regdatalab.com.